Corcept Therapeutics Incorporated (CORT) Social Stream



Corcept Therapeutics Incorporated (CORT): $31.61

4.09 (+14.86%)

POWR Rating

Component Grades

Momentum

D

Stability

C

Sentiment

Quality

A

Add CORT to Watchlist
Sign Up

Industry: Biotech

Industry

F

Ranked

#23 of 357

in industry

CORCEPT THERAPEUTICS INC (CORT) Price Targets From Analysts

The tables below show price targets and recommendations from analysts covering CORCEPT THERAPEUTICS INC.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Current Price Upside Potential
2021-11-04 4 $35 $16 $24.75 $23.45 5.54%
2022-01-26 4 $35 $16 $25.5 $23.45 8.74%
2022-01-28 5 $35 $16 $26.4 $23.45 12.58%
2022-02-02 6 $35 $16 $27 $23.45 15.14%
2022-04-19 6 $35 $16 $27.166 $23.45 15.85%
2022-05-06 6 $35 $16 $26.833 $23.45 14.43%
2022-07-13 6 $35 $16 $28.8 $23.45 22.81%
2022-07-27 6 $35 $16 $29.833 $23.45 27.22%
2022-08-01 6 $35 $16 $29.833 $23.45 27.22%
2022-08-04 6 $45 $16 $32.166 $23.45 37.17%
2022-11-07 6 $45 $18 $32.5 $23.45 38.59%
2022-12-02 6 $45 $18 $32.166 $23.45 37.17%
2022-12-09 6 $45 $18 $31.666 $23.45 35.04%
2022-12-20 6 $44 $18 $31.5 $23.45 34.33%
2023-02-14 6 $44 $18 $29.333 $23.45 25.09%
2023-03-01 6 $44 $18 $29 $23.45 23.67%
2023-03-28 6 $44 $18 $28.666 $23.45 22.24%
2023-04-04 7 $44 $18 $28.428 $23.45 21.23%
2023-05-04 6 $44 $18 $28 $23.45 19.4%
2023-05-26 8 $44 $18 $27.75 $23.45 18.34%
2023-07-25 7 $44 $18 $27.75 $23.45 18.34%
2023-08-03 7 $44 $18 $29 $23.45 23.67%
2023-08-04 7 $47.5 $18 $29.687 $23.45 26.6%
2023-08-25 8 $47.5 $18 $29.812 $23.45 27.13%
2023-10-19 8 $47.5 $18 $30.312 $23.45 29.26%
2023-11-02 8 $50 $18 $31.25 $23.45 33.26%
2023-11-07 7 $50 $20 $34.428 $23.45 46.81%
2023-12-13 6 $50 $27 $37 $23.45 57.78%

The Trend in the Analyst Price Target


Over the past 12 months, CORT's average price target has gone up $5.5.

CORT reports an average of 24.19% for its upside potential over the past 43 weeks.

Date Number of Analysts Highest Target Price Lowest Target Price Average Target Price Share Price Upside Potential
2023-03-01 6 44.0 18 29.000 19.86 46.02%
2023-04-11 8 44.0 18 28.000 22.06 26.93%
2023-05-26 8 44.0 18 27.750 23.98 15.72%
2023-10-19 8 47.5 18 30.312 28.00 8.26%
2023-11-07 6 50.0 20 34.428 25.74 33.75%

CORT Broker Recommendations Summary

Average Broker Rating Strong Buy Buy Hold Sell Strong Sell Analysts Issuing Recs
1.33 5 0 1 0 0 6

The Trend in the Broker Recommendations


Over the past 15 months, CORT's average broker recommendation rating improved by 0.5.

The points below can provide you with additional insight regarding what the price target and recommendations metrics in the table above mean for investors.

  • In terms of how CORCEPT THERAPEUTICS INC fares relative to all US stocks, note that its variance in analysts' estimates is lower than -2543.19% of that group.
  • To contextualize these metrics, consider that out of all US stocks, CORCEPT THERAPEUTICS INC's number of analysts covering the stock is higher than 986.98% of them.
  • In terms of how CORCEPT THERAPEUTICS INC fares relative to Pharmaceutical Products stocks, note that its upside potential (average analyst target price relative to current price) is greater than 837.62% of that group.
  • In terms of how CORCEPT THERAPEUTICS INC fares relative to stocks in the mid market cap category, note that its average analyst price target is higher than 1358.62% of that group.

In the Pharmaceutical Products industry, INVA, ACAD, and PTCT are the three stocks most similar to CORCEPT THERAPEUTICS INC regarding the price target and analyst recommendation information presented here.

What is the outlook for CORT? Use POWR Ratings for clearer insight into price direction.


Get Free Updates

Join thousands of investors who get the latest news, insights and top rated picks from StockNews.com!